Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Regeneron Pharmaceuticals
H. Lee Moffitt Cancer Center and Research Institute
Grey Wolf Therapeutics
OncoNano Medicine, Inc.
Vyriad, Inc.